NASDAQ:PRLD   Prelude Therapeutics Incorporated
PRLD has retraced to fib 0.95 and is close to the IPO price.
I am buying today.
First target - 60.
Second target - 90.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.